Raymond has secured a multi-programme aerospace contract worth ₹33 crore annually from a leading Indian aerospace and defence firm. The order covers more than 300 part numbers, including precision-machined, casting, and structural components for various aircraft applications. Production is scheduled to commence progressively across 2026 and 2027.

Order In Financial Context

The ₹33 crore annual order value represents approximately 5.5% of the company's average quarterly revenue of ₹596.15 crore. This win adds fresh visibility to the execution pipeline, although the total disclosed order book remains minimal relative to trailing twelve-month revenue. The current order book coverage stands at 0.00 quarters of average quarterly revenue, indicating that while this contract establishes a baseline, it does not significantly alter the immediate backlog.

Company Order Track Record

No previous order disclosures were recorded for Raymond in the last three fiscal quarters prior to this announcement. This ₹33 crore inflow marks the first disclosed win in this period, establishing a reference point for future comparison. As there is no prior data in the window, it is not possible to assess acceleration or deceleration in inflow velocity against typical per-order sizes.

Execution And Revenue Quality

Raymond's consolidated financials show improving operating margins over the last three quarters. Operating Profit Margin (OPM) expanded from 8.22% in Q3FY26 to 12.72% in Q1FY27, driven by higher operating profit growth outpacing revenue growth. Net profit also improved significantly, rising from ₹7.10 crore in Q3FY26 to ₹30.90 crore in Q1FY27. No quarters showed net loss or negative OPM, suggesting stable execution quality during this period.

Revenue Growth Context

Annual revenue has grown from ₹2,105.20 crore in FY25 to ₹2,311.80 crore in FY26, representing a YoY growth of +9.8%. This follows a strong recovery from FY24, where revenue grew by +85.1% year-on-year. The new aerospace order provides incremental visibility into future revenue streams beyond these historical trends.

Working Capital And Execution Capacity

The balance sheet indicates adequate liquidity for execution, with a current ratio of 1.72x and Total Liabilities/Equity of 0.52x. The low leverage suggests the company can fund working capital requirements without significant debt pressure. However, operating cashflow declined sharply to ₹41.80 crore in FY26 from ₹233.10 crore in FY25, resulting in negative free cashflow of -₹72.00 crore. This signals that while profitability improved, cash conversion efficiency weakened, potentially due to working capital cycles or capex intensity.

What To Watch

• Execution rate: Monitor whether the ₹33 crore aerospace order translates into revenue recognition as production commences in 2026-2027.
• OPM trajectory: Track if the improved Q1FY27 OPM of 12.72% sustains or normalizes as new contracts execute.
• Cash conversion: Watch for improvement in operating cashflow, given the decline to ₹41.80 crore in FY26.
• Client concentration: Assess if future orders diversify beyond this single Defence Major or remain concentrated.

Raymond Limited’s board has approved the issuance of 33.29 lakh convertible warrants to Minerva Ventures Fund via a preferential allotment. The transaction is valued at ₹214.71 crore, with each warrant priced at ₹645.

Fundraising details

The board meeting held on September 8, 2026, concluded with this specific fundraising decision. This move fulfills the agenda item regarding the review of equity fundraising plans through eligible instruments, including warrants. The issuance is subject to member approval and other statutory regulatory approvals.

Warrant terms

Each warrant carries an entitlement to subscribe to one fully paid-up equity share of face value ₹10 each, at an issue price of ₹645 per share (including a premium of ₹635 per share).

The warrants may be converted into equity shares in one or more tranches within a maximum period of 18 months from the date of allotment. Unconverted warrants shall lapse upon expiry of this period, and the upfront consideration paid towards such warrants will stand forfeited. Post-allotment, Minerva Ventures Fund’s holding will stand at 4.35% on a fully diluted basis, assuming full conversion of proposed as well as existing outstanding warrants.

Regulatory context

The approval aligns with the company’s earlier disclosure that it would consider raising funds through equity shares, convertible securities, or warrants via rights issues or preferential allotments. The trading window for designated persons remained closed from September 3, 2026, until September 10, 2026, in accordance with SEBI regulations and the company’s Code of Conduct for Prevention of Insider Trading.